版本:
中国

CORRECTED-BRIEF-Cascadian says stockholder Growth Equity Opportunities Fund IV has option to resell 1.82 mln of co's shares (May 8)

(Corrects May 8 brief headline to say company's stockholder Growth Equity Opportunities Fund IV, not Cascadian, may resell up to 1.82 million shares. Adds bullets with additional details of financing)

May 8 Cascadian Therapeutics Inc

* Files S-3 related to possible resale of up to 1.82 million shares of common stock by Growth Equity Opportunities Fund IV and its affiliates - SEC filing

* Growth Equity Opportunities Fund IV has option to resell common shares of the company, as part of Series E preferred stock financing announced in January by Cascadian

* S-3 filing is not related to a new secondary issue by Cascadian

* Cascadian will not receive any cash proceeds from the possible sale of any of shares of common stock by Growth Equity Opportunities Fund Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐